Aratana Therapeutics, Inc (PETX) Covered Calls

Aratana Therapeutics, Inc covered calls Aratana Therapeutics Inc is a development-stage biopharmaceutical company. It is engaged in licensing, development and commercialization of prescription medicines for pets.

You can sell covered calls on Aratana Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PETX (prices last updated Fri 4:16 PM ET):

Aratana Therapeutics, Inc (PETX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.27 -0.05 4.23 4.30 193K - 0.2B
Covered Calls For Aratana Therapeutics, Inc (PETX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 5 0.05 4.25 1.2% 19.9%
Apr 18 5 0.15 4.15 3.6% 23.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs (companion animals). The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.